VMD · Viemed Healthcare, Inc.

Summary

Viemed Healthcare, Inc. announced record Q4 and full year 2025 financial results with net revenues of $76.2 million and $270.3 million, net income of $5.6 million ($0.14 per diluted share) and $14.9 million ($0.37 per diluted share), and authorized a share repurchase program for up to 1,930,131 common shares through March 2027. The company issued 2026 guidance for net revenue of $310-$320 million and Adjusted EBITDA of $65-$69 million.

Key takeaways

• Event Type: Earnings Release and Share Repurchase Program (Items: 2.02, 8.01)